Arcturus Therapeutics/CSL Partnered COVID-19 Vaccine Surpasses Pfizer's Comirnaty Shot, Even At Lower Doses
CSL Limited (OTC:CSLLY) and Arcturus Therapeutics (NASDAQ:ARCT) announced the results of a Phase 3 head-to-head study of ARCT ...
ARCT Stock Up as Updated COVID-19 Jab Betters PFE & BNTX's Comirnaty
Arcturus stock gains as the company reports that its sa-mRNA COVID-19 vaccine, ARCT-154, shows superior efficacy compared ...
Regeneron loses key defense in COVID-19 treatment patent lawsuit
Biotech company Regeneron Pharmaceuticals lost a bid on Friday to be held immune from allegations that it misused a patented ...
COVID-19 boosters start rolling out to some Canadians. Who can get them?
Updated COVID-19 vaccines from Pfizer and Moderna targeting the latest variants of the virus are being offered to some ...
Calgary Herald on MSN6h
Doctors, nurses could be left out of Alberta COVID and flu vaccination campaign
Family doctors and nurse practitioners were told in a recent memo shared by Alberta Health that they will not receive ...
XEC is now in Australia. Here's what we know about this hybrid COVID variant
Over the nearly five years since COVID first emerged, you'd be forgiven if you've lost track of the number of new variants we ...
3 Sensational Ultrahigh-Yield Dividend Stocks That Make for No-Brainer Buys in the 4th Quarter (and Beyond)
Three high-octane income stocks -- sporting an average yield of 6.23% -- have the necessary tools and intangibles to make ...
Pfizer Is Rising Past Covid-19
Pfizer Inc. ( PFE, Financial) rose to prominence during the Covid-19 pandemic for its rapid development of a vaccine and ...
Novo Nordisk's Ozempic, Regeneron/Sanofi's Dupixent set to advance in top drug sales
AbbVie Humira, Pfizer/BioNTech COVID-19 shot may not make top 10 pharma drugs in 2024, with Novo Nordisk Ozempic and ...
CBC.ca10d
Pfizer's updated COVID-19 vaccine approved, Health Canada says
The federal vaccine and treatment portal lists authorization of the product Comirnaty, saying it includes an updated composition to target the KP.2 subvariant of Omicron. Pfizer said the newly ...